These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 23800539)

  • 21. Plasmodium falciparum merozoite surface antigen-specific cytophilic IgG and control of malaria infection in a Beninese birth cohort.
    Adamou R; Dechavanne C; Sadissou I; d'Almeida T; Bouraima A; Sonon P; Amoussa R; Cottrell G; Le Port A; Theisen M; Remarque EJ; Longacre S; Moutairou K; Massougbodji A; Luty AJF; Nuel G; Migot-Nabias F; Sanni A; Garcia A; Milet J; Courtin D
    Malar J; 2019 Jun; 18(1):194. PubMed ID: 31185998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Naturally Acquired Antibodies Target the Glutamate-Rich Protein on Intact Merozoites and Predict Protection Against Febrile Malaria.
    Kana IH; Adu B; Tiendrebeogo RW; Singh SK; Dodoo D; Theisen M
    J Infect Dis; 2017 Feb; 215(4):623-630. PubMed ID: 28329101
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunoglobulin G subclass-specific responses against Plasmodium falciparum merozoite antigens are associated with control of parasitemia and protection from symptomatic illness.
    Stanisic DI; Richards JS; McCallum FJ; Michon P; King CL; Schoepflin S; Gilson PR; Murphy VJ; Anders RF; Mueller I; Beeson JG
    Infect Immun; 2009 Mar; 77(3):1165-74. PubMed ID: 19139189
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibody responses to a panel of Plasmodium falciparum malaria blood-stage antigens in relation to clinical disease outcome in Sudan.
    Iriemenam NC; Khirelsied AH; Nasr A; ElGhazali G; Giha HA; Elhassan A-Elgadir TM; Agab-Aldour AA; Montgomery SM; Anders RF; Theisen M; Troye-Blomberg M; Elbashir MI; Berzins K
    Vaccine; 2009 Jan; 27(1):62-71. PubMed ID: 18977268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targets of complement-fixing antibodies in protective immunity against malaria in children.
    Reiling L; Boyle MJ; White MT; Wilson DW; Feng G; Weaver R; Opi DH; Persson KEM; Richards JS; Siba PM; Fowkes FJI; Takashima E; Tsuboi T; Mueller I; Beeson JG
    Nat Commun; 2019 Feb; 10(1):610. PubMed ID: 30723225
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Breadth of Functional Antibodies Is Associated With Plasmodium falciparum Merozoite Phagocytosis and Protection Against Febrile Malaria.
    Kana IH; Singh SK; Garcia-Senosiain A; Dodoo D; Singh S; Adu B; Theisen M
    J Infect Dis; 2019 Jun; 220(2):275-284. PubMed ID: 30820557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibody responses to repetitive epitopes of the circumsporozoite protein, liver stage antigen-1, and merozoite surface protein-2 in infants residing in a Plasmodium falciparum-hyperendemic area of western Kenya. XIII. Asembo Bay Cohort Project.
    Zhou Z; Xiao L; Branch OH; Kariuki S; Nahlen BL; Lal AA
    Am J Trop Med Hyg; 2002 Jan; 66(1):7-12. PubMed ID: 12135271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IgG antibody responses to Plasmodium falciparum merozoite antigens in Kenyan children have a short half-life.
    Kinyanjui SM; Conway DJ; Lanar DE; Marsh K
    Malar J; 2007 Jun; 6():82. PubMed ID: 17598897
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Declining Malaria Transmission Differentially Impacts the Maintenance of Humoral Immunity to Plasmodium falciparum in Children.
    Mugyenyi CK; Elliott SR; Yap XZ; Feng G; Boeuf P; Fegan G; Osier FFH; Fowkes FJI; Avril M; Williams TN; Marsh K; Beeson JG
    J Infect Dis; 2017 Oct; 216(7):887-898. PubMed ID: 28973483
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibody response against three Plasmodium falciparum merozoite antigens in Mamuju District, West Sulawesi Province, Indonesia.
    Sennang N; Rogerson S; Wahyuni S; Yusuf I; Syafruddin D
    Malar J; 2014 Sep; 13():381. PubMed ID: 25255775
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of antibodies to newly described Plasmodium falciparum merozoite antigens supports MSPDBL2 as a predicted target of naturally acquired immunity.
    Tetteh KK; Osier FH; Salanti A; Kamuyu G; Drought L; Failly M; Martin C; Marsh K; Conway DJ
    Infect Immun; 2013 Oct; 81(10):3835-42. PubMed ID: 23897617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Merozoite Antigens of Plasmodium falciparum Elicit Strain-Transcending Opsonizing Immunity.
    Hill DL; Wilson DW; Sampaio NG; Eriksson EM; Ryg-Cornejo V; Harrison GLA; Uboldi AD; Robinson LJ; Beeson JG; Siba P; Cowman AF; Hansen DS; Mueller I; Schofield L
    Infect Immun; 2016 Aug; 84(8):2175-2184. PubMed ID: 27185785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of the role of naturally acquired antibody levels to Plasmodium falciparum merozoite surface protein-1 in protecting Papua New Guinean children from malaria morbidity.
    al-Yaman F; Genton B; Kramer KJ; Chang SP; Hui GS; Baisor M; Alpers MP
    Am J Trop Med Hyg; 1996 May; 54(5):443-8. PubMed ID: 8644896
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction between maternally derived antibodies and heterogeneity in exposure combined to determine time-to-first Plasmodium falciparum infection in Kenyan infants.
    Reynaldi A; Dent AE; Schlub TE; Ogolla S; Rochford R; Davenport MP
    Malar J; 2019 Jan; 18(1):19. PubMed ID: 30670032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term clinical protection from falciparum malaria is strongly associated with IgG3 antibodies to merozoite surface protein 3.
    Roussilhon C; Oeuvray C; Müller-Graf C; Tall A; Rogier C; Trape JF; Theisen M; Balde A; Pérignon JL; Druilhe P
    PLoS Med; 2007 Nov; 4(11):e320. PubMed ID: 18001147
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differing rates of antibody acquisition to merozoite antigens in malaria: implications for immunity and surveillance.
    McCallum FJ; Persson KE; Fowkes FJ; Reiling L; Mugyenyi CK; Richards JS; Simpson JA; Williams TN; Gilson PR; Hodder AN; Sanders PR; Anders RF; Narum DL; Chitnis C; Crabb BS; Marsh K; Beeson JG
    J Leukoc Biol; 2017 Apr; 101(4):913-925. PubMed ID: 27837017
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytophilic Antibodies Against Key Plasmodium falciparum Blood Stage Antigens Contribute to Protection Against Clinical Malaria in a High Transmission Region of Eastern India.
    Kana IH; Garcia-Senosiain A; Singh SK; Tiendrebeogo RW; Chourasia BK; Malhotra P; Sharma SK; Das MK; Singh S; Adu B; Theisen M
    J Infect Dis; 2018 Aug; 218(6):956-965. PubMed ID: 29733355
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patterns of protective associations differ for antibodies to P. falciparum-infected erythrocytes and merozoites in immunity against malaria in children.
    Chan JA; Stanisic DI; Duffy MF; Robinson LJ; Lin E; Kazura JW; King CL; Siba PM; Fowkes FJ; Mueller I; Beeson JG
    Eur J Immunol; 2017 Dec; 47(12):2124-2136. PubMed ID: 28833064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Age-dependent IgG subclass responses to Plasmodium falciparum EBA-175 are differentially associated with incidence of malaria in Mozambican children.
    Dobaño C; Quelhas D; Quintó L; Puyol L; Serra-Casas E; Mayor A; Nhampossa T; Macete E; Aide P; Mandomando I; Sanz S; Puniya SK; Singh B; Gupta P; Bhattacharya A; Chauhan VS; Aponte JJ; Chitnis CE; Alonso PL; Menéndez C
    Clin Vaccine Immunol; 2012 Feb; 19(2):157-66. PubMed ID: 22169088
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Jahnmatz P; Nyabundi D; Sundling C; Widman L; Mwacharo J; Musyoki J; Otieno E; Ahlborg N; Bejon P; Ndungu FM; Färnert A
    Front Immunol; 2022; 13():799306. PubMed ID: 35355994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.